Most patients with stage four cancer are not considered candidates for definitive radiotherapy due to the challenge of treating multiple tumors. Our breakthrough technology is challenging that and aims to treat multiple tumors, in parallel, during a single session.
Treatment isn’t a one-size-fits-all situation. For many patients, the best treatment plan is a combination of multiple therapies. RefleXion will work together with chemotherapy, immunotherapy and targeted drugs for potentially better outcomes.
HAYWARD, Calif., May 09, 2019 — RefleXion Medical, a biotargeting oncology company using each cancer’s unique biology as a means to destroy it, today announced the opening of its new manufacturing facility at its headquarters in Hayward, Calif. The 50,000 square-foot facility includes six state-of-the-art linear accelerator testing vaults for the innovative RefleXion machine and […]
RefleXion Medical is preparing to ramp up production of its cancer-fighting machine, which leverages positron emission tomography (PET) imaging to target cancer with radiation therapy. The Hayward-based company hopes to have FDA clearance for its medical machine by year’s end, propelled by a $60 million credit facility from Oxford Finance LLC granted earlier this month. […]
This week’s post will build upon what we learned in our last entry, which reviewed the basics of radiotherapy. I highly recommend reading that post if you have not already, but a very quick summary is that radiotherapy can be thought of as shooting billions of tiny bullets at cancer cells, causing those cancer cells […]